Quantcast

Posts related to ‘VVUS’

24/7 Wall St. Closing Bell

The major US stock indexes opened significantly lower this morning as investors reacted to the surprise loss of $2 billion by JPMorgan Chase & Co. (NYSE: JPM) disclosed by the ...
Read Full Story »

Biotechs Bucking The Dendreon Trap & Curse (DNDN, VRTX, VVUS, ARNA, ALNY, AMGN, SVNT)

When we issued our earnings previews for the week ahead, it looked as though Dendreon Corporation (NASDAQ: DNDN) had a chance of really setting the trend for the entire biotech ...
Read Full Story »

The 8 Earnings Reports Shaping The Week Ahead (DNDN, EA, RAX, DIS, CSCO, M, NUAN)

24/7 Wall St. often looks at the key earnings reports scheduled for the week ahead.  We have the bulk of the S&P 500 earnings behind us and we are now ...
Read Full Story »

Fast-Acting Erectile Dysfunction Drug Penetrates The Market

Men with erectile dysfunction can get relief twice as quickly as was possible in the past. VIVUS, Inc. (NASDAQ: VVUS) received FDA approval for STENDRA (avanafil) tablets. The firm says that ...
Read Full Story »

Options Traders Extending Out to September in VIVUS (VVUS)

VIVUS Inc. (NASDAQ: VVUS) was trying to recover this morning and briefly spent some time in positive territory after an obvious concern for shareholders that the FDA is not quite ...
Read Full Story »

VIVUS Faces Shareholder Risks After FDA Delay On Obesity Pill (VVUS, ARNA, OREX)

VIVUS Inc. (NASDAQ: VVUS) is getting a bit of a haircut this morning on the heels of some news from the Food & Drug Administration which may throw up some ...
Read Full Story »

Top Analyst Upgrades & Downgrades (BBY, BWLD, CR, EMC, EXLP, GPS, IBN, INVN, LULU, MU, PAAS, BTU, RTN, RIMM, VVUS)

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Friday. Best Buy Co. Inc. (NYSE: BBY) Maintained Hold at Argus. Buffalo ...
Read Full Story »

Arena Files for European Drug Review (ARNA, VVUS, OREX)

Drug maker Arena Pharmaceuticals Inc. (NASDAQ: ARNA) announced that its application to sell its lorcaserin weight-loss drug in Europe has been accepted by the Europe Medicines Agency. This is the ...
Read Full Story »

24/7 Wall St. Closing Bell (CVX, WMB, YRCW, CVC, APOL, FSLR, VVUS, KOG, CZR, CEP, DRH, END, SPLS, JOY, SEMG, FORD, GEVO, QUAD, VOCS, SODA)

The three major US stock indexes opened higher this morning on the better-than-expected news on US GDP growth (our coverage here). The buying mood turning sour as the Nasdaq neared ...
Read Full Story »

24/7 Wall St. Top Analyst Calls of the Week (BX, APO, CMA, DELL, DANG, EXM, FSLR, GILD, LVLT, ERIC, MAR, ORCL, SUN, VVUS, WBMD)

Each weekend we review the many analyst calls we track during the week.  Some turn out to be very insightful and some turn out to be not so great.  For ...
Read Full Story »

24/7 Wall St. Closing Bell (CHK, LVLT, TJX, HPQ, JNPR, ANGI, SAM, CBOU, DRYS, FLS, FLR, GDP, KBR, AMT, BBG, CTHR, DDS, DISH, FWLT, OMX, TGT, VVUS, ONVI, SHLD, PVA, GTI)

After a flat opening this morning, markets turned down before reversing course in mid-morning to return to positive territory, where they spent the rest of the day. A good report ...
Read Full Story »

Mid-day Movers (VVUS, ONVI, SHLD, AWAY, GTI)

Shortly before noon ET today, all three major US stock indexes are showing gains, with the DJIA up about 47 points at about 12,985, the Nasdaq up more than 19 ...
Read Full Story »

Morning Movers (VVUS, ONVI, CTHR, PPO, GNK)

The three major US equities indexes opened about flat this morning as US jobless claims came in near expectations at 351,000 new claims (our coverage here). The European Commission’s forecast ...
Read Full Story »

Top Analyst Upgrades & Downgrades (BRCD, CAB, CHK, CEO, EXM, HPQ, JNPR, LVLT, ERIC, MELI, PTR, POOL, TJX, VVUS)

These are some of this Thursday's top analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Brocade Communications Systems Inc. (NASDAQ: BRCD) Reiterated Hold at Argus. Cabela's, Inc. ...
Read Full Story »

VIVUS Scores FDA Backing For Qnexa Against Obesity (VVUS, OREX, ARNA)

VIVUS, Inc. (NASDAQ: VVUS) is going to likely have a huge day on Thursday.  The FDA panel reviewing its Qnexa drug to treat obesity has voted overwhelmingly to offer FDA panel backing ...
Read Full Story »